TipRanks
Ansell (CH:PD1A)
:PD1A
Switzerland Market
PD1A
Ansell
RESEARCH TOOLSreports

Ansell (PD1A) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

PD1A Analyst Ratings

Hold
8Ratings
Hold
1 Buy
7 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Ansell
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PD1A Stock 12 Month Forecast

Average Price Target

―
Based on 8 Wall Street analysts offering 12 month price targets for Ansell in the last 3 months. The average price target is CHF22.75 with a high forecast of CHF25.84 and a low forecast of CHF21.98. The average price target represents a ― change from the last price of ―.
eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCwgLWFwcGxlLXN5c3RlbSwgQmxpbmtNYWNTeXN0ZW1Gb250LCBTZWdvZSBVSSwgUm9ib3RvLCBIZWx2ZXRpY2EsIEFyaWFsLCBzYW5zLXNlcmlmLCBBcHBsZSBDb2xvciBFbW9qaSwgU2Vnb2UgVUkgRW1vamksIFNlZ29lIFVJIFN5bWJvbCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==
Highest Price TargetCHF25.84Average Price TargetCHF22.75Lowest Price TargetCHF21.98
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:PD1A
Craig Wong-Pan
RBC Capital
RBC Capital
CHF20.9→CHF22.06
Hold
―
Downgraded
09/15/26
RBC Capital downgrades Ansell (ANSLF) to a Hold
Citi Analyst forecast on CH:PD1A
Laura Sutcliffe
Citi
Citi
CHF22.93
Hold
―
Reiterated
09/10/26
Citi Keeps Their Hold Rating on Ansell (ANSLF)
Morgan Stanley Analyst forecast on CH:PD1A
David Bailey
Morgan Stanley
Morgan Stanley
CHF18.99→CHF22
Hold
―
Reiterated
08/31/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Abbott Laboratories (NYSE: ABT), PTC Therapeutics (NASDAQ: PTCT) and Ansell (Other OTC: ANSLF)
Macquarie Analyst forecast on CH:PD1A
Unknown Analyst
Macquarie
Not Ranked
Macquarie
CHF20.49→CHF22.41
Hold
―
Reiterated
08/25/26
Ansell (ANSLF) Gets a Hold from Macquarie
Ord Minnett Analyst forecast on CH:PD1A
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
CHF20.06→CHF22.29
Hold
―
Downgraded
08/25/26
Ord Minnett downgrades Ansell (ANSLF) to a Hold
Jefferies Analyst forecast on CH:PD1A
Vanessa Thomson
Jefferies
Jefferies
CHF22.18→CHF25.84
Buy
―
Reiterated
08/25/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Capricor Therapeutics (NASDAQ: CAPR), Ansell (Other OTC: ANSLF) and Erasca (NASDAQ: ERAS)
UBS Analyst forecast on CH:PD1A
David Low
UBS
UBS
CHF19.89→CHF22.47
Hold
―
Reiterated
08/25/26
Ansell (ANSLF) Receives a Hold from UBS
Morgans Analyst forecast on CH:PD1A
Derek Jellinek
Morgans
Morgans
CHF21.98
Hold
―
Reiterated
08/25/26
Morgans Reaffirms Their Hold Rating on Ansell (ANSLF)
Goldman Sachs Analyst forecast on CH:PD1A
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
CHF18.46
Hold
―
Initiated
04/07/26
Ansell Limited: Efficiency Gains Offset by Margin Pressures and Unclear Growth Trajectory Support Hold Rating
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CH:PD1A
Craig Wong-Pan
RBC Capital
RBC Capital
CHF20.9→CHF22.06
Hold
―
Downgraded
09/15/26
RBC Capital downgrades Ansell (ANSLF) to a Hold
Citi Analyst forecast on CH:PD1A
Laura Sutcliffe
Citi
Citi
CHF22.93
Hold
―
Reiterated
09/10/26
Citi Keeps Their Hold Rating on Ansell (ANSLF)
Morgan Stanley Analyst forecast on CH:PD1A
David Bailey
Morgan Stanley
Morgan Stanley
CHF18.99→CHF22
Hold
―
Reiterated
08/31/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Abbott Laboratories (NYSE: ABT), PTC Therapeutics (NASDAQ: PTCT) and Ansell (Other OTC: ANSLF)
Macquarie Analyst forecast on CH:PD1A
Unknown Analyst
Macquarie
Not Ranked
Macquarie
CHF20.49→CHF22.41
Hold
―
Reiterated
08/25/26
Ansell (ANSLF) Gets a Hold from Macquarie
Ord Minnett Analyst forecast on CH:PD1A
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
CHF20.06→CHF22.29
Hold
―
Downgraded
08/25/26
Ord Minnett downgrades Ansell (ANSLF) to a Hold
Jefferies Analyst forecast on CH:PD1A
Vanessa Thomson
Jefferies
Jefferies
CHF22.18→CHF25.84
Buy
―
Reiterated
08/25/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Capricor Therapeutics (NASDAQ: CAPR), Ansell (Other OTC: ANSLF) and Erasca (NASDAQ: ERAS)
UBS Analyst forecast on CH:PD1A
David Low
UBS
UBS
CHF19.89→CHF22.47
Hold
―
Reiterated
08/25/26
Ansell (ANSLF) Receives a Hold from UBS
Morgans Analyst forecast on CH:PD1A
Derek Jellinek
Morgans
Morgans
CHF21.98
Hold
―
Reiterated
08/25/26
Morgans Reaffirms Their Hold Rating on Ansell (ANSLF)
Goldman Sachs Analyst forecast on CH:PD1A
Davinthra Thillainathan
Goldman Sachs
Goldman Sachs
CHF18.46
Hold
―
Initiated
04/07/26
Ansell Limited: Efficiency Gains Offset by Margin Pressures and Unclear Growth Trajectory Support Hold Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
WSTWest Pharmaceutical Services
ZYMEZymeworks
SLDBSolid Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ansell

3 Months
Vanessa ThomsonJefferies
Success Rate
8/9 ratings generated profit
89%
Average Return
+10.02%
Copying Vanessa Thomson's trades and holding each position for 3 Months would result in 88.89% of your transactions generating a profit, with an average return of +10.02% per trade.
1 Year
Vanessa ThomsonJefferies
Success Rate
9/9 ratings generated profit
100%
Average Return
+20.70%
Copying Vanessa Thomson's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.70% per trade.
2 Years
Vanessa ThomsonJefferies
Success Rate
9/9 ratings generated profit
100%
Average Return
+12.66%
Copying Vanessa Thomson's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.66% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PD1A Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
1
2
4
4
2
Hold
2
4
11
13
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
6
15
17
12
In the current month, PD1A has received 2 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. PD1A average Analyst price target in the past 3 months is 22.75.
Each month's total comprises the sum of three months' worth of ratings.

PD1A Financial Forecast

PD1A Earnings Forecast

Next quarter’s earnings estimate for PD1A is CHF0.64 with a range of CHF0.61 to CHF0.66. The previous quarter’s EPS was CHF0.68. PD1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.
Next quarter’s earnings estimate for PD1A is CHF0.64 with a range of CHF0.61 to CHF0.66. The previous quarter’s EPS was CHF0.68. PD1A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.

PD1A Sales Forecast

Next quarter’s sales forecast for PD1A is CHF911.51M with a range of CHF897.07M to CHF937.70M. The previous quarter’s sales results were CHF920.30M. PD1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.
Next quarter’s sales forecast for PD1A is CHF911.51M with a range of CHF897.07M to CHF937.70M. The previous quarter’s sales results were CHF920.30M. PD1A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PD1A has Performed in-line its overall industry.

PD1A Stock Forecast FAQ

What is CH:PD1A’s average 12-month price target, according to analysts?
Based on analyst ratings, Ansell’s 12-month average price target is 22.75.
    What is CH:PD1A’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:PD1A, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Ansell a Buy, Sell or Hold?
        Ansell has a consensus rating of Hold, which is based on 1 buy ratings, 7 hold ratings and 0 sell ratings.
          What is Ansell’s share price target?
          The average share price target for Ansell is 22.75. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF25.84 ,and the lowest forecast is CHF21.98. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Ansell?
            Ansell’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
              How can I buy shares of Ansell?
              To buy shares of CH:PD1A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.